Journal
VACCINE
Volume 22, Issue 27-28, Pages 3722-3726Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2004.03.027
Keywords
Japanese encephalitis virus; ChimeriVax (TM)-JE; genotype
Categories
Ask authors/readers for more resources
The ability of antiscra raised against a candidate Japanese encephalitis virus (JEV) vaccine, ChimeriVax(TM)-JE, and the currently licensed vaccine, JE-VAX(R), to protect against strains of JEV representing the four major genotypes was assessed. Neutralization assays and passive protection studies in mice showed that greatest protection was provided against strains of genotypes II and III, although some protection was also afforded against genotypes I and IV strains. Chimerivax(TM)-JE stimulated protection that was comparable or superior to the JE-VAX(R) control. (C) 2004 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available